QuantiFERON-TB Gold for School or Work: What You Need to Know
Learn what to verify before ordering QuantiFERON-TB Gold Plus for school, clinical training, healthcare employment, or another workplace requirement.
Medically reviewed by Rhonda Collins, FNP-C | Mito Health on August 28, 2026.
QuantiFERON-TB Gold Plus is a TB blood test that many schools, clinical programs, and employers may accept for tuberculosis screening. Acceptance is not universal. Before ordering, verify the test type, result date, paperwork, signature, and any jurisdiction-specific rules your institution requires.
What does QuantiFERON-TB Gold Plus measure?
QuantiFERON-TB Gold Plus is an interferon-gamma release assay, or IGRA. It measures how immune cells in a blood sample respond to proteins associated with Mycobacterium tuberculosis, the bacteria that cause TB. The CDC identifies QuantiFERON-TB Gold Plus as an FDA-approved IGRA.
The test looks for evidence of TB infection. It cannot distinguish inactive TB infection from active TB disease on its own. A positive result requires medical evaluation and additional testing.
Why do schools and employers request TB screening?
TB screening may be part of a policy for people who study, train, work, or volunteer in settings where exposure or transmission would carry added concern. Common examples include:
- Nursing, medical, dental, and allied-health programs
- Hospitals, clinics, laboratories, and emergency medical services
- Long-term care and home-health settings
- Correctional facilities and some shelters
- Other jobs or programs with an institution-specific screening policy
This list describes common contexts, not a promise that every program uses the same rule. Some institutions accept either a blood or skin test. Others specify a method, a time window, a form, or additional evaluation based on prior results.
What is the baseline guidance for healthcare personnel?
CDC guidance recommends baseline TB screening when U.S. healthcare personnel are hired. Baseline screening includes an individual risk assessment, symptom evaluation, a TB test for people without documented prior TB infection or disease, and further evaluation when needed. These elements come from the CDC’s healthcare-personnel screening guidance.
An employer’s process may add requirements based on state or local rules. CDC recommendations do not replace those rules, so use the policy supplied by your employer or occupational-health team.
Do healthcare workers need a TB test every year?
Not universally. CDC does not recommend routine annual testing for U.S. healthcare personnel after baseline unless there has been a known exposure or ongoing transmission in the facility. Annual TB education and symptom awareness remain part of CDC infection-control guidance.
Your employer, school, licensing body, or jurisdiction may apply a different requirement. Verify the current policy instead of assuming that a prior annual schedule still applies.
What should you verify before ordering?
Ask the person or office that reviews your records:
- Is an IGRA accepted, and is QuantiFERON-TB Gold Plus specifically acceptable?
- How recent must the collection date or result be?
- Is the laboratory report enough, or is a school or employer form required?
- Does the form need a clinician signature or occupational-health review?
- Do prior positive tests or prior TB treatment change what you need to submit?
- Are there separate state, licensing, clinical-site, immigration, or program rules?
- What happens if the result is positive or indeterminate?
Confirming these details first helps avoid ordering a valid test that does not match the exact administrative requirement.
What happens during collection and after the result?
QuantiFERON-TB Gold Plus uses a blood sample and requires one blood-draw visit. Unlike a tuberculin skin test, it does not require a return visit to have a skin reaction measured. Fasting is not required for this test alone.
After the laboratory reports the result, follow your institution’s submission process. The product page owns current ordering and availability details, while your institution owns the documentation it will accept.
What happens after a positive or indeterminate result?
A positive result supports TB infection but does not diagnose active TB disease. Medical evaluation is needed to distinguish inactive infection from active disease. That evaluation commonly includes a symptom review and chest imaging and may include additional tests, as outlined in the CDC’s testing and diagnosis guidance.
An indeterminate result does not establish whether infection is present. Depending on your risk, symptoms, and program requirements, a clinician may recommend repeating the blood test or using a different TB test.
If you have TB symptoms, do not wait for school or employment paperwork. Seek prompt medical evaluation even if a screening result is negative.
What if you were exposed recently or had a prior positive test?
Testing very soon after exposure can produce a negative result before the immune response becomes detectable. Ask a clinician or public-health program whether your exposure timing calls for follow-up testing.
If you have written documentation of a previous positive blood or skin test or prior TB treatment, repeat testing may not add useful information because many people remain positive. Ask the institution what documentation and evaluation it requires instead of automatically ordering another test.
Ordering the exact blood test
Once you confirm that an IGRA and the available documentation fit your requirement, you can order Mito’s Tuberculosis Blood Test (QuantiFERON-TB Gold Plus). The product page provides the current purchase and collection flow.
Still deciding between testing methods? Compare the TB blood test and PPD skin test workflows, including visit count, BCG vaccination, interpretation, and limitations.
This article is for educational purposes and does not replace medical advice, diagnosis, or treatment.